Our collective will and intellects are being called upon to manage COVID-19, save lives, and restore our economy. During this public health emergency, it is crucial that every sector of our health care system step up to the challenge. And
A World Without Pharmacy Benefit Companies… …Means Employers Would Have to Go it Alone Pharmacy benefit companies play an important and unique role in the drug supply and payment chain. While they are best known for lowering drug costs through
The Medicare Prescription Drug Rebate Rule The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate rule clumsily attempts to eliminate the primary tool used by
(Washington, D.C.) — In honor of World Diabetes Day, the Pharmaceutical Care Management Association (PCMA) has launched a new phase of the OnYourRxSide campaign that showcases how pharmacy benefit managers, PBMs, are working to improve the lives of patients living
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
Medium: Pharmacy Benefit Managers – Providing Lower Prescription Costs for State Medicaid Programs Dealing with COVID-19 June 5, 2020 Given this growing challenge, pharmacy benefit managers (PBMs) have never been more essential. For both public programs and private insurance, PBMs
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on legislation introduced by Senate Finance Committee members: The just-released Senate Finance Committee legislation enables Big Pharma to profit immensely from the high list prices big
New Research Paper Demonstrates Declining Biosimilars Prices and Increasing Health Plan Coverage (Washington, D.C.) — Pharmacy benefit managers, PBMs, support the proliferation and use of biosimilars. A robust biosimilar market will increase competition for biologic drugs and provide added choice
What Problem is Congress Trying to Solve? (Washington D.C.) – The Pharmaceutical Care Management Association released the following statement on today’s votes in the Senate Finance Committee and the Ways and Means Committee: Today, as two congressional committees vote on
©2024 PCMA. All Rights Reserved.
